ArticleOncotarget2016
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.
Lynsey Vaughan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ArticleOncotarget2016
Lynsey Vaughan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.